HAE - Comprehensive Filing Intelligence

FYNone•10-Q•Filed Feb 5, 2026
6.0/10
Filing Health:GOOD

Solid fundamentals with minor concerns to monitor

Executive Summary

Gross and operating margins are improving due to a shift to higher-margin products, innovation, and reduced restructuring costs.. Revenue performance was mixed, with growth in Plasma and Hospital segments offset by declines in Blood Center due to a divestiture and customer transition.. The company has $1,224,733 in total debt, with convertible senior notes maturing on March 1, 2026, which will require settlement via cash on hand or revolving credit facility.. Plasma revenue increased 2.8% (constant currency) in Q3 FY26 due to U.S. plasma collections and innovation.

Top Concerns

  • !Revenue performance was mixed, with growth in Plasma and Hospital segments offset by declines in Blood Center due to a divestiture and customer transition.
  • !Acquisition of Vivasure Medical Limited includes up to $98.9 million in contingent consideration, increasing future uncertainty.
  • !The company has $1,224,733 in total debt, with convertible senior notes maturing on March 1, 2026, which will require settlement via cash on hand or revolving credit facility.
  • !Competition and Obsolescence (medium)
  • !Supply Chain Disruptions (medium)

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

7.0/10

Management tone is confidently optimistic with focus on transformation of the product portfolio to higher margin offerings.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

7.0/10

Earnings quality shows moderate accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is low.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

6.0/10

Overall risk profile shows competition and obsolescence as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

6.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.